DoW Breast Cancer, Clinical Research Extension Award
Defense Health Agency Contracting Activity - DHACA
- Funding range
- $0 – $8.4M
- Application window
- Opens: Not listed
- Closes: November 18, 2026
- Applications Status:Open
- Location
- National
Source & verification
- Original funding source
- www.grants.gov
- Last checked
- October 27, 2026
- Last reviewed by Ryplle
- Not yet recorded
Source checks may be automated. Review dates reflect a recorded staff review. Confirm current requirements with the funder.
Eligibility at a glance
- Listed applicant types
- Nonprofit
- Geographic eligibility
- National
- Matching funds
- Not specified — check with the funder
- Major exclusions
- Not specified — check with the funder
Listed types are not a determination of eligibility. The funder’s full requirements take precedence.
Full eligibility requirements
Eligible applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility".
About this grant
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this award mechanism is to increase the clinically relevant impact of breast cancer patient participation in clinical studies by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Distinctive Features: • The research team must include two or more breast cancer consumer advocates. • This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.
Contact information
- Danielle Reckley Grantor
- help@eBRAP.org
- 301-619-1139

